HCPCS Q0081: Infusion Therapy, Non-Chemotherapeutic, Per Visit
HCPCS Level II code Q0081 designates infusion therapy for administration of drugs other than chemotherapeutic agents, billed on a per-visit basis. This code is used across outpatient settings where patients receive intravenous or other infused non-oncology medications and is relevant to facility and professional billing for infusion services. Nationally, non-chemotherapy infusions represent a significant component of outpatient care for chronic and acute conditions managed with biologics, monoclonal antibodies, immunotherapies, and supportive medications.
Key payers in the coverage landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for infusion visits, common payer coverage considerations, and operational benchmarks when available. The publication highlights coding intent, typical sites of service, and the administrative role of per-visit billing for infusion therapy. It will also summarize common modifiers and areas where policy updates or clarification are frequently sought. Where input data is not provided, the report notes that information is not available in the input.
Sign up for hcpcs Q0081 policy alerts
Get alerted when payer policies referencing Q0081 are released or updated.
Billing Code Overview
HCPCS Level II code Q0081 describes infusion therapy using non-chemotherapeutic drugs, billed per visit. The service type is infusion therapy for administration of medications other than chemotherapeutic agents. The typical site of service is outpatient infusion settings such as hospital outpatient departments, infusion centers, physician offices, or other ambulatory care settings where medication is administered by clinical staff on a per-visit basis.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with chronic iron-deficiency anemia presents to an outpatient infusion center for parenteral iron therapy. The patient has oral iron intolerance and prior inadequate response to oral supplementation. A registered nurse performs pre-infusion vitals and verifies indication, medication, and consent. The clinician orders an infusion of an FDA-approved non-chemotherapeutic agent (for example, intravenous iron sucrose or ferric carboxymaltose). The infusion visit includes medication preparation by pharmacy, administration via peripheral IV or existing vascular access, continuous monitoring for infusion reactions, and post-infusion observation for 30–60 minutes. Documentation includes start and stop times, total medication administered, patient tolerance, any medications administered for adverse reactions, and discharge instructions. Billing for the visit uses HCPCS Level II code Q0081 to report infusion therapy using non-chemotherapeutic drugs per visit, with applicable modifier appended when indicated to reflect professional component, unusual circumstances, or multiple procedures during the same encounter.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier / default | Rarely reported separately; some payors require no modifier field when no special circumstance applies |
22 | Increased procedural services | When the infusion required substantially greater resources or time due to clinical complexity (document intensity) |
23 | Unusual anesthesia | If medically necessary anesthesia is provided for the infusion procedure (rare for standard infusions) |
26 | Professional component | When billing separately for the clinician's professional interpretation or supervision distinct from the facility component |
32 | Unrelated evaluation and management service by the same physician during the postoperative period | If an unrelated E/M is performed and documented on the same day as the infusion visit |
52 | Reduced services | When the infusion was started but not completed and services are reduced accordingly |
53 | Discontinued procedure | When the infusion is terminated due to patient intolerance or adverse event before completion |
59 | Distinct procedural service | When a separately identifiable infusion-related procedure or service is performed on the same day (use with appropriate documentation) |
76 | Repeat procedure or service by same provider | For additional separate infusion visits performed by the same provider on the same day when payor rules permit |
78 | Unplanned return to the operating/procedure room by the same provider following initial procedure for a related procedure during the postoperative period | Rare for infusion therapy; use only for documented return for complication management requiring procedural intervention |
AS | Allocation of anesthesia services (Medicare-specific) | When anesthesia is provided and allocation reporting is required by Medicare |
QK | Medical direction of two, three, or four certified registered nurse anesthetists (CRNAs) | Use only if anesthesia services meet the regulatory definition and are applicable |
QX | CRNA service with medical direction by a physician | Same context as QK when applicable |
QY | Medical direction of one CRNA by an anesthesiologist | Same context as QK when applicable |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
253E00000X | Infusion Nurse | RN or infusion-trained nurse performing administration and monitoring |
207Q00000X | Hematology | Hematologist ordering and overseeing iron or other infusion therapies |
207L00000X | Allergy & Immunology | Allergy specialists administering biologic non-chemotherapeutic infusions (e.g., omalizumab) |
208D00000X | Gastroenterology | Gastroenterologist managing patients with malabsorption requiring parenteral therapies |
207K00000X | Internal Medicine | Primary care internists coordinating infusion therapy in outpatient settings |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
D50.0 | Iron deficiency anemia secondary to blood loss (chronic) | Common indication for IV iron when oral therapy fails or is not tolerated |
D50.9 | Iron deficiency anemia, unspecified | General indication for parenteral iron therapy when diagnosis is iron deficiency |
K50.90 | Crohn's disease, unspecified, without complications | Inflammatory bowel disease causing malabsorption or chronic blood loss leading to need for IV iron |
K51.90 | Ulcerative colitis, unspecified, without complications | Another inflammatory bowel disease indication for parenteral iron due to malabsorption or bleeding |
N18.9 | Chronic kidney disease, unspecified | CKD patients frequently require IV iron for anemia of chronic disease, especially on dialysis |
C80.1 | Malignant (primary) neoplasm, unspecified — metastatic disease | Patients with cancer-related anemia may receive non-chemotherapeutic supportive infusions (e.g., iron, growth factors) |
Z79.01 | Long term (current) use of anticoagulants | Anticoagulation can contribute to chronic blood loss and anemia, prompting IV iron therapy |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | Commonly reported for administration of IV non-chemotherapeutic drugs when reporting infusion time-based CPT alongside or instead of HCPCS depending on payer rules |
96366 | Intravenous infusion, each additional hour (List separately in addition to code for primary service) | Used when infusion exceeds the initial hour and additional hourly reporting is required |
96367 | Additional sequential infusion (same day), up to 1 hour | For an additional, separate infusion session on the same day when clinically distinct |
96374 | Therapeutic, prophylactic, or diagnostic injection (specify substance) | Used for single therapeutic injections administered IV or IM during the visit in addition to infusion |
36000 | Introduction of needle or catheter into peripheral vein for diagnostic or therapeutic purposes (venipuncture) | If separate venous access is obtained during the visit and reported separately per payer policy |
36415 | Collection of venous blood by venipuncture | Often performed for pre-infusion labs; billed separately if performed and allowable by payor |